U.S., May 28 -- ClinicalTrials.gov registry received information related to the study (NCT07609355) titled 'AI-Assisted Optimization of Online Adaptive Radiotherapy for Gastric Lymphoma' on May 07.
Brief Summary: The goal of this clinical trial is to evaluate CBCT image-based triggered online adaptive radiotherapy (ART) and assess its clinical benefits in protecting organs at risk (OARs).
Study Start Date: May 08
Study Type: INTERVENTIONAL
Condition:
Lymphoma of the Mucosa Associated Lymphoid Tissue (MALT)
Intervention:
RADIATION: ART
All participants will receive intensity-modulated radiation therapy (IMRT) or volumetric modulated arc therapy (VMAT). To ensure study quality, all radiation therapy plans will undergo review by the re...